Studies of gene–environment interactions may help us to understand the disease mechanisms of common and complex diseases such as Parkinson's disease (PD). Sporadic PD, the common form of PD, is thought to be a multifactorial disorder caused by combinations of multiple genetic factors and environmental or life-style exposures. Since one of the most extensively studied life-style factors in PD is coffee/caffeine intake, here, the studies of genetic polymorphisms with life-style interactions of sporadic PD are reviewed, focusing on coffee/caffeine intake.
Get full access to this article
View all access options for this article.
References
1.
WirdefeldtK, AdamiHO, ColeP, TrichopoulosD, MandelJ. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol, 2011; 26:S1–58.
2.
CortiO, LesageS, BriceA. What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev, 2011; 91:1161–218.
3.
PolymeropoulosMH, LavedanC, LeroyE, et al.Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 1997; 276:2045–2047.
4.
ZimprichA, BiskupS, LeitnerP, et al.Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 2004; 44:601–607.
5.
KitadaT, AsakawaS, HattoriN, et al.Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998; 392:605–608.
6.
ValenteEM, Abou-SleimanPM, CaputoV, et al.Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 2004; 304:1158–1160.
7.
BonifatiV, RizzuP, van BarenMJ, et al.Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 2003; 299:256–259.
8.
RamirezA, HeimbachA, GründemannJ, et al.Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet, 2006; 38:1184–1191.
9.
EdwardsTL, ScottWK, AlmonteC, et al.Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet, 2010; 74:97–109.
10.
SatakeW, NakabayashiY, MizutaI, et al.Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet, 2009; 41:1303–1307.
11.
PankratzN, WilkJB, LatourelleJC, et al.Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet, 2009; 124:593–605.
12.
HamzaTH, ZabetianCP, TenesaA, et al.Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet, 2010; 42:781–785.
13.
LillCM, RoehrJT, McQueenMB, et al.Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet, 2012; 8:e1002548.
14.
BonifatiV. Genetics of Parkinson's disease—state of the art, 2013. Parkinsonism Relat Disord, 2014; 20:S23–28.
15.
WirdefeldtK, AdamiHO, ColeP, TrichopoulosD, MandelJ. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol, 2011; 26:S1–58.
16.
FallPA, FredriksonM, AxelsonO, GranérusAK. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord, 1999; 14:28–37.
17.
NefzgerMD, QuadfaselFA, KarlVC. A retrospective study of smoking in Parkinson's disease. Am J Epidemiol, 1968; 88:149–158.
18.
PowersKM, KayDM, FactorSA, et al.Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Mov Disord, 2008; 23:88–95.
19.
BenedettiMD, BowerJH, MaraganoreDM, et al.Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology, 2000; 55:1350–1358.
20.
HancockDB, MartinER, StajichJM, et al.Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. Arch Neurol, 2007; 64:576–580.
21.
HellenbrandW, SeidlerA, BoeingH, et al.Diet and Parkinson's disease. I: a possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology, 1996; 47:636–643.
22.
Paganini-HillA. Risk factors for Parkinson's disease: the leisure world cohort study. Neuroepidemiology, 2001; 20:118–124.
23.
TanEK, TanC, Fook-ChongSM, et al.Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci, 2003; 216:163–167.
24.
RagoneseP, SalemiG, Morgante, et al.A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease. Neuroepidemiology, 2003; 22:297–304.
25.
AscherioA, ZhangSM, HernánMA, et al.Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol, 2001; 50:56–63.
26.
AscherioA, WeisskopfMG, O'ReillyEJ, et al.Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen. Am J Epidemiol, 2004; 160:977–984.
27.
HernánMA, TakkoucheB, Caamaño-IsornaF, Gestal-OteroJJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol, 2002; 52:276–284.
28.
CostaJ, LunetN, SantosC, SantosJ, Vaz-CarneiroA. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. J Alzheimers Dis, 2010; 20:S221–238.
29.
GaoJ, NallsMA, ShiM, et al.An exploratory analysis on gene–environment interactions for Parkinson disease. Neurobiol Aging, 2012; 33:2528.e1–6.
30.
MiyakeY, TanakaK, FukushimaW, et al.Lack of association between BST1 polymorphisms and sporadic Parkinson's disease in a Japanese population. J Neurol Sci, 2012; 323:162–166.
31.
UK Parkinson's Disease Consortium; Wellcome Trust Case Control Consortium 2, SpencerCC, PlagnolV, StrangeA, et al.Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet, 2011; 20:345–353.
32.
SaadM, LesageS, Saint-PierreA, et al.Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet, 2011; 20:615–627.
33.
ChangXL, MaoXY, LiHH, et al.Association of GWAS loci with PD in China. Am J Med Genet B Neuropsychiatr Genet, 2011; 156B:334–339.
34.
International Parkinson Disease Genomics Consortium; NallsMA, PlagnolV, HernandezDG, et al.Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 2011; 377:641–649.
35.
HancockDB, MartinER, VanceJM, ScottWK. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Neurogenetics, 2008; 9:249–262.
36.
SulemP, GudbjartssonDF, GellerF, et al.Sequence variants at CYP1A1-CYP1A2 and AHR associate with coffee consumption. Hum Mol Genet, 2011; 20:2071–2077.
37.
AminN, ByrneE, JohnsonJ, et al.Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry, 2012; 17:1116–1129.
38.
SachseC, BrockmöllerJ, BauerS, RootsI. Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol, 1999; 47:445–449.
39.
KachrooA, SchwarzschildMA. Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease. Ann Neurol, 2012; 71:278–282.
40.
XiaoD, CassinJJ, HealyB, et al.Deletion of adenosine A1 or A(2A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease. Brain Res, 2011; 1367:310–318.
41.
SinghK, SinghS, SinghalNK, SharmaA, ParmarD, SinghMP. Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: implications in neuroprotection mechanism. Chem Biol Interact, 2010; 185:81–93.
42.
BoehmlerW, PetkoJ, WollM, et al.Identification of zebrafish A2 adenosine receptors and expression in developing embryos. Gene Expr Patterns, 2009; 9:144–151.
43.
CoccurelloR, BreysseN, AmalricM. Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats. Neuropsychopharmacology, 2004; 29:1451–1461.
44.
FacherisMF, SchneiderNK, LesnickTG, et al.Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord, 2008; 23:2033–2040.
45.
TanEK, ChuaE, Fook-ChongSM, et al.Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers. Pharmacogenet Genom, 2007; 17:1001–1005.
46.
PalaciosN, WeisskopfM, SimonK, GaoX, SchwarzschildM, AscherioA. Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women. Parkinsonism Relat Disord, 2010; 16:370–375.
47.
PopatRA, Van Den EedenSK, TannerCM, et al.Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol, 2011; 18:756–765.
48.
Hill-BurnsEM, HamzaTH, ZabetianCP, FactorSA, PayamiH. An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease. Eur J Neurol, 2011; 18:e107–108.
49.
MellickGD, RossOA. Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene–environment interactions?. Eur J Neurol, 2011; 18:671–672.
50.
PopatRA, Van Den EedenSK, TannerCM, et al.Response to Hill-Burns et al. letter: an attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease. Eur J Neurol, 2011; 18:e109.
51.
HamzaTH, ChenH, Hill-BurnsEM, et al.Genome-wide gene–environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee. PLoS Genet, 2011; 7:e1002237.
52.
Yamada-FowlerN, FredriksonM, SöderkvistP. Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson's disease in Swedish population. PLoS One, 2014; 9:e99294.
53.
TsuboiY. Environmental–genetic interactions in the pathogenesis of Parkinson's disease. Exp Neurobiol, 2012; 21:123–128.
54.
ElbazA, LevecqueC, ClavelJ, et al.CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol, 2004; 55:430–434.
55.
DengY, NewmanB, DunneMP, SilburnPA, MellickGD. Further evidence that interactions between CYP2D6 and pesticide exposure increase risk for Parkinson's disease. Ann Neurol, 2004; 55:897.
56.
KeladaSN, Costa-MallenP, CostaLG, et al.Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease. Neurotoxicology, 2002; 23:515–519.
57.
HerraizT, ChaparroC. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee. Life Sci, 2006; 78:795–802.
